OA08506A - Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. - Google Patents

Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.

Info

Publication number: OA08506A
Authority: OA; OAPI
Prior art keywords: compounds; prophylaxis; treatment; disorders; agents containing
Prior art date: 1986-03-27

Application number

OA59095A

Other languages

English (en)

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-27

Filing date

1987-03-27

Publication date

1988-07-29

1987-03-27 Application filed by Hoechst Ag filed Critical Hoechst Ag

1988-07-29 Publication of OA08506A publication Critical patent/OA08506A/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)
Epoxy Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Cosmetics (AREA)

OA59095A 1986-03-27 1987-03-27 Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. OA08506A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19863610391 DE3610391A1 (de)	1986-03-27	1986-03-27	Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number	Publication Date
OA08506A true OA08506A (fr)	1988-07-29

Family

ID=6297417

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA59095A OA08506A (fr)	1986-03-27	1987-03-27	Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.

Country Status (25)

Country	Link
EP (1)	EP0243645B1 (fr)
JP (1)	JPS62240698A (fr)
KR (1)	KR870008841A (fr)
CN (1)	CN1031267C (fr)
AT (1)	ATE102954T1 (fr)
AU (1)	AU621278B2 (fr)
CA (1)	CA1341064C (fr)
CS (2)	CS276179B6 (fr)
DD (1)	DD280765A5 (fr)
DE (2)	DE3610391A1 (fr)
DK (1)	DK172221B1 (fr)
EG (1)	EG18175A (fr)
ES (1)	ES2061447T3 (fr)
FI (1)	FI91876C (fr)
HU (2)	HU202118B (fr)
IE (1)	IE62456B1 (fr)
MA (1)	MA20919A1 (fr)
NO (1)	NO178546C (fr)
NZ (1)	NZ219764A (fr)
OA (1)	OA08506A (fr)
PH (1)	PH27210A (fr)
PT (1)	PT84564B (fr)
RU (1)	RU1836335C (fr)
TN (1)	TNSN87045A1 (fr)
ZA (1)	ZA872230B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5231084A (en) *	1986-03-27	1993-07-27	Hoechst Aktiengesellschaft	Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) *	1987-02-24	1988-05-10	Warner-Lambert Company	Stabilized compositions
AU612137B2 (en) *	1987-04-27	1991-07-04	E.R. Squibb & Sons, Inc.	Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) *	1987-09-16	1989-04-06	Hoechst Ag	Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) *	1987-11-24	1989-06-08	Hoechst Ag	Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) *	1988-01-21	1989-08-03	Hoechst Ag	Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (fr) *	1988-01-27	1992-07-01	Hoechst Aktiengesellschaft	Inhibiteurs de l'enzyme de conversion à activité psychotrope
DE3803225A1 (de) *	1988-02-04	1989-08-17	Hoechst Ag	Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) *	1988-03-21	1989-11-06	E R Squibb & Sons Inc	晩発性運動障害の抑制治療剤
US5037821A (en) *	1988-06-01	1991-08-06	E. R. Squibb & Sons, Inc.	Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) *	1989-01-30	1992-03-03	E. R. Squibb & Sons, Inc.	Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) *	1990-09-17	1991-07-16	E. R. Squibb & Sons, Inc.	Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
CA2442717A1 (fr) *	2001-03-15	2002-09-26	Saegis Pharmaceuticals, Inc.	Methodes permettant de retablir la fonction cognitive suite a un stress systemique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3174844D1 (en) *	1980-10-23	1986-07-24	Schering Corp	Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3300774A1 (de) *	1983-01-12	1984-07-12	Hoechst Ag, 6230 Frankfurt	Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
1987
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-18 EP EP87103938A patent/EP0243645B1/fr not_active Expired - Lifetime
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 CA CA000533092A patent/CA1341064C/fr not_active Expired - Lifetime
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Application Discontinuation
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-27 CS CS872126A patent/CS276179B6/cs unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
- 1987-03-27 CS CS896519A patent/CS276385B6/cs not_active IP Right Cessation
- 1987-03-27 OA OA59095A patent/OA08506A/fr unknown

Also Published As

Publication number	Publication date
CS212687A3 (en)	1992-04-15
PT84564A (de)	1987-04-01
PH27210A (en)	1993-05-04
FI871304A0 (fi)	1987-03-25
PT84564B (pt)	1989-11-10
AU7064987A (en)	1987-10-01
CN1031267C (zh)	1996-03-13
FI91876B (fi)	1994-05-13
NZ219764A (en)	1990-11-27
NO871282D0 (no)	1987-03-26
EP0243645A3 (en)	1990-01-24
ES2061447T3 (es)	1994-12-16
DK153587D0 (da)	1987-03-26
CS276179B6 (en)	1992-04-15
HU202118B (en)	1991-02-28
DE3789330D1 (de)	1994-04-21
IE62456B1 (en)	1995-02-08
EG18175A (en)	1994-07-30
FI91876C (fi)	1994-08-25
CN87102304A (zh)	1987-12-30
TNSN87045A1 (fr)	1990-01-01
DD280765A5 (de)	1990-07-18
IE870784L (en)	1987-09-27
JPS62240698A (ja)	1987-10-21
HU203117B (en)	1991-05-28
NO178546B (no)	1996-01-08
DE3610391A1 (de)	1987-10-08
KR870008841A (ko)	1987-10-21
AU621278B2 (en)	1992-03-12
DK153587A (da)	1987-09-28
CS651989A3 (en)	1992-05-13
EP0243645B1 (fr)	1994-03-16
CS276385B6 (en)	1992-05-13
EP0243645A2 (fr)	1987-11-04
MA20919A1 (fr)	1987-10-01
RU1836335C (ru)	1993-08-23
HU896609D0 (en)	1990-02-28
HUT46046A (en)	1988-09-28
FI871304A (fi)	1987-09-28
DK172221B1 (da)	1998-01-12
NO871282L (no)	1987-09-28
CA1341064C (fr)	2000-08-01
ATE102954T1 (de)	1994-04-15
NO178546C (no)	1996-04-17
ZA872230B (en)	1987-09-21

Publication	Publication Date	Title
OA08506A (fr)	1988-07-29	Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.
MC2272A1 (fr)	1993-06-23	Utilisation de la substance active nommee flupirtine pour combattre des contractures musculaires
IL89031A0 (en)	1989-08-15	Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
FR2541115B1 (fr)	1988-12-23	Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
FR2430408A1 (fr)	1980-02-01	Phenethanolamines optiquement actives et leur utilisation therapeutique
EP0261595A3 (en)	1990-01-24	Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus
DE69330150D1 (de)	2001-05-23	Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
ES8604597A1 (es)	1986-02-16	Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
PH24094A (en)	1990-03-05	5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
DE69327207D1 (de)	2000-01-13	Tryptamine zur Behandlung von Störungen der circadianen Rhythmik
EP0999204A4 (fr)	2001-10-04	Nouveau compose capable de promouvoir une differenciation neuronale
IL83586A0 (en)	1988-01-31	Substituted hexahydroarylquinolizines and pharmaceutical compositions containing them
IT8719882A0 (it)	1987-03-27	Solfidril-composti per sopprimere gli effetti inibitori di prodotti di degradazione nad sull'attivita'ld-l.
ATE72115T1 (de)	1992-02-15	Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
ATE122889T1 (de)	1995-06-15	Verwendung von mizoribin zur behandlung oder vorbeugung der multiplen sklerose.
DE68909399D1 (de)	1993-10-28	Verwendung von Gangliosiden zur Behandlung der Dysfunktion des autonomen Nervensystems bei der Chagas-Krankheit.
EP0228034A3 (en)	1990-05-09	Arginine and agmatine derivatives for treating protozoal infections
RO95371B1 (ro)	1988-07-31	Medicament pentru tratamentul unor afectiuni alergice cronice
IT8722734A0 (it)	1987-11-24	Apparecchiatura per la rigenerazione e depurazione del sangue.
ZA89574B (en)	1989-09-27	Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
EP0178176A3 (en)	1988-03-23	Tetrahydro-1,2,4-oxadiazine-5-thione derivatives